Cargando…
Identification of DDX60 as a Regulator of MHC-I Class Molecules in Colorectal Cancer
Immune checkpoint blockade (ICB) therapies induce durable responses in approximately 15% of colorectal cancer (CRC) patients who exhibit microsatellite instability-high (MSI-H) or deficient mismatch repair (dMMR). However, more than 80% of CRC patients do not respond to current immunotherapy. The ma...
Autores principales: | Geng, Nina, Hu, Tuo, He, Chunbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775109/ https://www.ncbi.nlm.nih.gov/pubmed/36551849 http://dx.doi.org/10.3390/biomedicines10123092 |
Ejemplares similares
-
Role of non-classical MHC class I molecules in cancer immunosuppression
por: Kochan, Grazyna, et al.
Publicado: (2013) -
Non-classical MHC Class I molecules regulating natural killer cell function
por: Smyth, Mark J., et al.
Publicado: (2013) -
The mode of action of tapasin on major histocompatibility class I (MHC-I) molecules
por: Lan, By Huan, et al.
Publicado: (2023) -
MHC Class I Regulation: The Origin Perspective
por: Sznarkowska, Alicja, et al.
Publicado: (2020) -
Presentation of Exogenous Antigens on Major Histocompatibility Complex (MHC) Class I and MHC Class II Molecules Is Differentially Regulated during Dendritic Cell Maturation
por: Delamarre, Lélia, et al.
Publicado: (2003)